Companies news Santé - médical - pharmaceutique

Cerapro® MED launches in Europe

Hyphens Pharma International announces the European launch of Cerapro® MED Skin Barrier Cream, entering six markets this year through a partnership with Louis Widmer SA: Switzerland, Liechtenstein, Austria, Belgium, Luxembourg and the Netherlands.

Cerapro® MED is a patented, CE-marked medical device under the EU Medical Device Regulation (MDR). By lowering skin pH, it helps restore the skin barrier and supports the skin’s natural antimicrobial defenses, addressing a key underlying factor of atopic dermatitis.

This partnership marks an important step in bringing science-backed dermatological solutions to patients across Europe. ⚕️

SOURCE: HYPHENS PHARMA INTERNATIONAL